Riskpilot← Back to searchSign inGet full accessDocVikum Aktiebolag
ABIn liquidationOrg 5567399430General medical practice activities · NACE 8621Est. 20071 employees
Revenue 2020
SEK 15K
-93% vs 2019
EBITDA margin
-426.7%
-152% vs 2019
Equity ratio
87.3%
Financial strength
Net profit 2020
SEK 196K
+151% vs 2019
| Revenue | SEK 15K | -93% |
| EBITDA | SEK -64K | -152% |
| Net profit | SEK 196K | +151% |
| Total assets | SEK 897K | -51% |
| Equity | SEK 783K | -44% |
| Employees | 1 | — |
Legal name
DocVikum Aktiebolag
Org number
5567399430
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
15 oktober 2007
Share capital
SEK 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-08-31
Financial year
January – December
Company purpose
Bolaget ska tillhandahålla läkarkompetens i allmänmedicin och utföra behandlingar och uppdrag inom svensk primärvård, förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Revenue | 720 | 557 | 617 | 201 | 15 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 608 | 409 | 528 | 124 | −64 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 608 | 409 | 528 | 124 | −64 |
| Net financials | 7 | 3 | 5 | 6 | 7 |
| Profit before tax | 1 028 | 312 | 403 | 100 | 252 |
| Tax | −227 | −69 | −89 | −22 | −56 |
| Net profit | 801 | 243 | 314 | 78 | 196 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|
| Total assets | 1 261 | 1 494 | 1 790 | 1 845 | 897 |
| Equity | 912 | 995 | 1 309 | 1 387 | 783 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 299 | 349 | 201 | 149 | 114 |
| Total debt | 299 | 349 | 201 | 149 | 114 |
EBITDA margin
-426.7%
This company
15.8%
Market median
-2801% vs market
20162020
Equity ratio
87.3%
This company
38.2%
Market median
+129% vs market
20162020
Return on equity
25.0%
This company
18.4%
Market median
+36% vs market
20162020
Net profit margin
1306.7%
This company
8.1%
Market median
+16032% vs market
20162020
Asset turnover
0.02×
This company
1.12×
Market median
-98% vs market
20162020
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20162020
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
DG Liquidator | Liquidator | 2020 | — | — |
LG Liquidator | Liquidator | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DocVikum Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| David Glavonjic | Liquidator | 0 companies |
| Leif Gustaf Malmborg | Liquidator | 0 companies |
| Ylva Gunhild Birgitta Segerbo | Board of Directors | 0 companies |
| Ewa Irene Segerbo | Deputy Board Member | 0 companies |